These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 32857725)

  • 41. Upregulated microRNA-194 impairs stemness of cholangiocarcinoma cells through the Rho pathway via inhibition of ECT2.
    Gao J; Dai C; Yu X; Yin XB; Zhou F
    J Cell Biochem; 2020 Oct; 121(10):4239-4250. PubMed ID: 31960990
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long non-coding RNA MIR22HG inhibits cell proliferation and migration in cholangiocarcinoma by negatively regulating the Wnt/β-catenin signaling pathway.
    Hu X; Tan Z; Yang Y; Yang P
    J Gene Med; 2019 May; 21(5):e3085. PubMed ID: 30856284
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Targeting the PI3K/AKT/mTOR pathway offer a promising therapeutic strategy for cholangiocarcinoma patients with high doublecortin-like kinase 1 expression.
    Liang Z; Ge Y; Li J; Bai Y; Xiao Z; Yan R; An G; Zhang D
    J Cancer Res Clin Oncol; 2024 Jul; 150(7):342. PubMed ID: 38980538
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Long non-coding RNA VPS9D1-AS1 enhances proliferation, invasion, and epithelial-mesenchymal transition in endometrial cancer via miR-377-3p/SGK1.
    Peng TF; Zhou YJ; Zhou J; Zhou Y; Li XC; Ouyang Q
    Kaohsiung J Med Sci; 2022 Nov; 38(11):1048-1059. PubMed ID: 36245426
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long non-coding RNA HOTAIR promotes tumorigenesis and forecasts a poor prognosis in cholangiocarcinoma.
    Qin W; Kang P; Xu Y; Leng K; Li Z; Huang L; Gao J; Cui Y; Zhong X
    Sci Rep; 2018 Aug; 8(1):12176. PubMed ID: 30111807
    [TBL] [Abstract][Full Text] [Related]  

  • 46. MORC2 promotes cell growth and metastasis in human cholangiocarcinoma and is negatively regulated by miR-186-5p.
    Liao G; Liu X; Wu D; Duan F; Xie X; Wen S; Li Y; Li S
    Aging (Albany NY); 2019 Jun; 11(11):3639-3649. PubMed ID: 31180332
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A PLCB1-PI3K-AKT Signaling Axis Activates EMT to Promote Cholangiocarcinoma Progression.
    Liang S; Guo H; Ma K; Li X; Wu D; Wang Y; Wang W; Zhang S; Cui Y; Liu Y; Sun L; Zhang B; Xin M; Zhang N; Zhou H; Liu Y; Wang J; Liu L
    Cancer Res; 2021 Dec; 81(23):5889-5903. PubMed ID: 34580062
    [TBL] [Abstract][Full Text] [Related]  

  • 48. YY1-induced DLEU1/miR-149-5p Promotes Malignant Biological Behavior of Cholangiocarcinoma through Upregulating YAP1/TEAD2/SOX2.
    Li J; Jiang X; Xu Y; Kang P; Huang P; Meng N; Wang H; Zheng W; Wang H; Wang Z; Zhong X; Cui Y
    Int J Biol Sci; 2022; 18(11):4301-4315. PubMed ID: 35864972
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Decrease of miR-622 expression promoted the proliferation, migration and invasion of cholangiocarcinoma cells by targeting regulation of c-Myc.
    Wu YF; Li ZR; Cheng ZQ; Yin XM; Wu JS
    Biomed Pharmacother; 2017 Dec; 96():7-13. PubMed ID: 28961507
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antitumor activity of celastrol by inhibition of proliferation, invasion, and migration in cholangiocarcinoma via PTEN/PI3K/Akt pathway.
    Zhu B; Wei Y
    Cancer Med; 2020 Jan; 9(2):783-796. PubMed ID: 31957323
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Up-regulation of ZFAS1 indicates dismal prognosis for cholangiocarcinoma and promotes proliferation and metastasis by modulating USF1 via miR-296-5p.
    Li Z; Jiang X; Huang L; Li J; Ji D; Xu Y; Leng K; Cui Y
    J Cell Mol Med; 2019 Dec; 23(12):8258-8268. PubMed ID: 31565837
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Knockdown of long non-coding RNA HOXD-AS1 inhibits the progression of osteosarcoma.
    Qu Y; Zheng S; Kang M; Dong R; Zhou H; Zhao D; Zhao J
    Biomed Pharmacother; 2018 Feb; 98():899-906. PubMed ID: 29571260
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Circ-LAMP1 contributes to the growth and metastasis of cholangiocarcinoma via miR-556-5p and miR-567 mediated YY1 activation.
    Xu Y; Gao P; Wang Z; Su Z; Liao G; Han Y; Cui Y; Yao Y; Zhong X
    J Cell Mol Med; 2021 Apr; 25(7):3226-3238. PubMed ID: 33675150
    [TBL] [Abstract][Full Text] [Related]  

  • 54. LncRNA CDKN2B-AS1/miR-141/cyclin D network regulates tumor progression and metastasis of renal cell carcinoma.
    Dasgupta P; Kulkarni P; Majid S; Hashimoto Y; Shiina M; Shahryari V; Bhat NS; Tabatabai L; Yamamura S; Saini S; Tanaka Y; Dahiya R
    Cell Death Dis; 2020 Aug; 11(8):660. PubMed ID: 32814766
    [TBL] [Abstract][Full Text] [Related]  

  • 55. LncRNA ADPGK-AS1 promotes pancreatic cancer progression through activating ZEB1-mediated epithelial-mesenchymal transition.
    Song S; Yu W; Lin S; Zhang M; Wang T; Guo S; Wang H
    Cancer Biol Ther; 2018 Jul; 19(7):573-583. PubMed ID: 29667486
    [TBL] [Abstract][Full Text] [Related]  

  • 56. SOX2 knockdown slows cholangiocarcinoma progression through inhibition of transcriptional activation of lncRNA PVT1.
    Yu A; Zhao L; Kang Q; Li J; Chen K; Fu H
    Biochem J; 2020 Sep; 477(18):3527-3540. PubMed ID: 32812642
    [TBL] [Abstract][Full Text] [Related]  

  • 57. LncRNA LOXL1-AS1 inhibited cell proliferation, migration and invasion as well as induced apoptosis in breast cancer via regulating miR-143-3p.
    Li GH; Yu JH; Yang B; Gong FC; Zhang KW
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10400-10409. PubMed ID: 31841194
    [TBL] [Abstract][Full Text] [Related]  

  • 58. LncRNA TTN-AS1 promotes the progression of cholangiocarcinoma via the miR-320a/neuropilin-1 axis.
    Zhu H; Zhai B; He C; Li Z; Gao H; Niu Z; Jiang X; Lu J; Sun X
    Cell Death Dis; 2020 Aug; 11(8):637. PubMed ID: 32801339
    [TBL] [Abstract][Full Text] [Related]  

  • 59. LncRNA MT1JP plays a protective role in intrahepatic cholangiocarcinoma by regulating miR-18a-5p/FBP1 axis.
    Zhao W; Zhao J; Guo X; Feng Y; Zhang B; Tian L
    BMC Cancer; 2021 Feb; 21(1):142. PubMed ID: 33557774
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Long non-coding RNA titin-antisense RNA1 contributes to growth and metastasis of cholangiocarcinoma by suppressing microRNA-513a-5p to upregulate stratifin.
    Liu Y; Sun J; Qi P; Liu Y
    Bioengineered; 2021 Dec; 12(2):12611-12624. PubMed ID: 34903127
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.